Title : Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.

Pub. Date : 2019 Nov

PMID : 31740864






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung. erlotinib epidermal growth factor receptor Homo sapiens
2 Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung. erlotinib epidermal growth factor receptor Homo sapiens
3 Objective: To assess the efficacy and tolerability of erlotinib in combination with radiation therapy followed by maintenance therapy in Stage III and IV, epidermal growth factor receptor mutationpositive adenocarcinoma lung patients. erlotinib epidermal growth factor receptor Homo sapiens
4 CONCLUSIONS: Concurrent radiotherapy with erlotinib was effective and well-tolerated in patients with locally advanced adenocarcinoma lung harbouring epidermal growth factor receptor mutation. erlotinib epidermal growth factor receptor Homo sapiens